Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SLC16A8 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5115908
Description
Antibody detects endogenous levels of total SLC16A8.
SLC16A8 is proton-linked monocarboxylate transporter. It catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate.
Specifications
| SLC16A8 | |
| Polyclonal | |
| Unconjugated | |
| SLC16A8 | |
| LOW QUALITY PROTEIN: monocarboxylate transporter 3; MCT 3; MCT3; monocarboxylate transporter; monocarboxylate transporter 3; monocarboxylate transporter 3; LOW QUALITY PROTEIN: monocarboxylate transporter 3; preferentially expressed in RPE cells and choroid plexus epithelium; proton-coupled monocarboxylate transporter 3; REMP; Slc16a8; solute carrier 16 (monocarboxylic acid transporters), member 8; solute carrier family 16 (monocarboxylate transporter), member 8; solute carrier family 16 (monocarboxylic acid transporters), member 8; solute carrier family 16 member 8; solute carrier family 16, member 8 (monocarboxylic acid transporter 3) | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 23539, 57274, 65200 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide | |
| O35308, O70461, O95907 | |
| SLC16A8 | |
| A synthesized peptide derived from human SLC16A8(Accession O95907), corresponding to amino acid residues S452-E502. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction